Evidence map›Paper›PMID 36401520›Full record

ArticleCell transplantation

Gap Junction-Mediated Transport of Metabolites Between Stem Cells and Vascular Endothelial Cells.

Yuko Ogawa, Rie Akamatsu, Akihiro Fuchizaki, Kazuta Yasui, Orie Saino, Mitsunobu Tanaka, Akie Kikuchi-Taura, Takafumi Kimura, Akihiko Taguchi

Open access · goldAbstract read
In one paragraph

Article in Cell transplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Frontiers in cellular and infection microbiology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Unlocking the code for stroke treatment and care.Journal of central nervous system disease · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yuko OgawaDepartment of Regenerative Medicine Research, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan.ORCID 0000-0002-5862-4436
Rie AkamatsuDepartment of Regenerative Medicine Research, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan.
Akihiro FuchizakiJapanese Red Cross Kinki Block Blood Center, Osaka, Japan.
Kazuta YasuiJapanese Red Cross Kinki Block Blood Center, Osaka, Japan.
Orie SainoDepartment of Regenerative Medicine Research, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan.
Mitsunobu TanakaJapanese Red Cross Kinki Block Blood Center, Osaka, Japan.
Akie Kikuchi-TauraDepartment of Regenerative Medicine Research, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan.
Takafumi KimuraJapanese Red Cross Kinki Block Blood Center, Osaka, Japan.
Akihiko TaguchiDepartment of Regenerative Medicine Research, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Japan.
Foundation for Biomedical Research and Innovation · JPJapanese Red Cross Society, Japan · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have previously demonstrated that small molecular transfer, such as glucose, between hematopoietic stem cells (HSCs) or mesenchymal stem cells (MSCs) and vascular endothelial cells via gap junctions constitutes an important mechanism of stem cell therapy. Cell metabolites are high-potential small-molecule candidates that can be transferred to small molecules between stem cells and vascular endothelial cells. Here, we investigated the differences in metabolite levels between stem cells (HSCs and MSCs), vascular endothelial cells, and the levels of circulating non-hematopoietic white blood cells (WBCs). The results showed remarkable differences in metabolite concentrations between cells. Significantly higher concentrations of adenosine triphosphate (ATP), guanosine triphosphate (GTP), total adenylate or guanylate levels, glycolytic intermediates, and amino acids were found in HSCs compared with vascular endothelial cells. In contrast, there was no significant difference in the metabolism of MSCs and vascular endothelial cells. From the results of this study, it became clear that HSCs and MSCs differ in their metabolites. That is, metabolites that transfer between stem cells and vascular endothelial cells differ between HSCs and MSCs. HSCs may donate various metabolites, several glycolytic and tricarboxylic acid cycle metabolites, and amino acids to damaged vascular endothelial cells as energy sources and activate the energy metabolism of vascular endothelial cells. In contrast, MSCs and vascular endothelial cells regulate each other under normal conditions. As the existing MSCs cannot ameliorate the dysregulation during insult, exogenous MSCs administered by cell therapy may help restore normal metabolic function in the vascular endothelial cells by taking up excess energy sources from the lumens of blood vessels. Results of this study suggested that the appropriate timing of cell therapy is different between HSCs and MSCs.

Indexed as

Endothelial CellsHematopoietic Stem CellsAmino AcidsCells, CulturedGap JunctionsAmino Acidscirculating CD34-negative and CD45-positive white blood cellsgap junctionhematopoietic stem cellshuman umbilical vein endothelial cellsmesenchymal stem cells

Identifiers

PMID36401520
PMCPMC9679345
OpenAlexW4309654693

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.